The Filing Desk

Bioharvest Sciences vs Bon Natural Life

Bioharvest Sciences BHST · Bon Natural Life BON · Personal Care Products

Bioharvest Sciences reported revenue of $34 million in fiscal 2025, 1.8 times Bon Natural Life's $19 million in fiscal 2025. Bioharvest Sciences' revenue grew 37.0% in its latest year, and Bon Natural Life's fell 21.7%. Bioharvest Sciences had an operating margin of -16.2%, against -8.7% at Bon Natural Life. Free cash flow was −$10 million at Bioharvest Sciences and $0 million at Bon Natural Life. Their fiscal years end in different months (December 31 and September 30), so the periods don't line up exactly.

Side by side

Bioharvest SciencesBon Natural Life
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Sep 30, 2025
Revenue$34M$19M
Revenue growth37.0%−21.7%
Revenue growth a year, last 5 years—0.5%
Gross margin59.3%20.8%
Operating margin−16.2%−8.7%
Net margin−32.3%−10.7%
Free cash flow−$10M$0M
Free cash flow margin−27.8%0.7%
Return on capital—−2.2%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count—2,766.6%
Last close$1.32$1.05
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score—2 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Bioharvest SciencesBon Natural Life
Operating margin
Percent of revenue
Bioharvest SciencesBon Natural Life
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Bioharvest SciencesBon Natural Life

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Bioharvest Sciences and Bon Natural Life pages.